Company NanoVibronix Inc OTC Bulletin Board
Equities
NAOV
US63008J1088
Medical Equipment, Supplies & Distribution
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Noninvasive Biological Response-activating Devices
100.0
%
| 1 | 100.0 % | 2 | 100.0 % | +203.59% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
94.7
%
| 1 | 94.4 % | 2 | 94.7 % | +204.51% |
Europe
4.4
%
| 0 | 3.3 % | 0 | 4.4 % | +304.00% |
Australia
0.8
%
| 0 | 1.2 % | 0 | 0.8 % | +111.11% |
Israel
0.0
%
| - | - | 0 | 0.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Harold Jacob
FOU | Founder | 69 | 31/08/03 |
Brian Murphy
CEO | Chief Executive Officer | 67 | 12/10/16 |
Stephen Brown
DFI | Director of Finance/CFO | 67 | 02/02/15 |
Lindsey Harrison
SAM | Sales & Marketing | - | 31/03/21 |
Itai Levinson
SAM | Sales & Marketing | - | 31/03/18 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Mika
BRD | Director/Board Member | 72 | 26/04/15 |
Chairman | 74 | 13/11/16 | |
Aurora Cassirer
BRD | Director/Board Member | 72 | 31/12/21 |
Harold Jacob
FOU | Founder | 69 | 31/08/03 |
Michael Ferguson
BRD | Director/Board Member | 53 | 26/04/15 |
Martin Goldstein
BRD | Director/Board Member | 56 | 24/03/15 |
Brian Murphy
CEO | Chief Executive Officer | 67 | 12/10/16 |
Maria Schroeder
BRD | Director/Board Member | 65 | 12/01/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,784,354 | 2,772,619 ( 99.58 %) | 0 | 99.58 % |
Company contact information
NanoVibronix, Inc.
525 Executive Boulevard
10523-1240, Elmsford
+(914) 233-3004
http://www.nanovibronix.com![address NanoVibronix Inc(NAOV)](https://cdn.zonebourse.com/static/address/22033598.png)
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-6.20% | 180B | |
-3.13% | 106B | |
-4.45% | 67.55B | |
-5.22% | 46.11B | |
+13.95% | 45.79B | |
+2.58% | 41.61B | |
+19.21% | 31.07B | |
+11.40% | 24.77B | |
-3.73% | 24.27B |